Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
about
Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
description
scientific article published on 18 June 2020
@en
wetenschappelijk artikel
@nl
name
Publisher Correction: Safety a ...... ory non-small-cell lung cancer
@en
Publisher Correction: Safety a ...... ory non-small-cell lung cancer
@nl
type
label
Publisher Correction: Safety a ...... ory non-small-cell lung cancer
@en
Publisher Correction: Safety a ...... ory non-small-cell lung cancer
@nl
prefLabel
Publisher Correction: Safety a ...... ory non-small-cell lung cancer
@en
Publisher Correction: Safety a ...... ory non-small-cell lung cancer
@nl
P2093
P1433
P1476
Publisher Correction: Safety a ...... ory non-small-cell lung cancer
@en
P2093
Bingwen Zou
Binwu Ying
Chong Chen
Haige Shen
Jianxin Xue
P356
10.1038/S41591-020-0973-6
P50
P577
2020-06-18T00:00:00Z